Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill directs HHS to study how often hospital emergency departments test overdose patients for fentanyl, estimate costs, assess benefits and risks, and examine effects on patient experience including privacy and patient‑physician relationships. Within six months after the study, HHS must issue guidance on whether EDs should routinely test for fentanyl, how clinicians should know which substances are screened, and how testing could affect overdose risk and health outcomes.
Privacy and law‑enforcement access concerns versus public‑health data use
Relative to its intended legislative type, this bill is a clearly focused study-and-guidance statute that assigns HHS specific topics and firm deadlines but lacks resourcing, methodological detail, and robust accountability provisions.
The bill directs HHS to study how often hospital emergency departments test overdose patients for fentanyl, estimate costs, assess benefits and risks, and examine effects on patient experience including privacy and patient‑physician relationships.
Within six months after the study, HHS must issue guidance on whether EDs should routinely test for fentanyl, how clinicians should know which substances are screened, and how testing could affect overdose risk and health outcomes.
The term "hospital emergency department" is defined by existing Social Security Act language.
Low-cost, noncontroversial advisory bill has reasonable prospects, but many such technical measures fail to advance amid competing priorities.
Relative to its intended legislative type, this bill is a clearly focused study-and-guidance statute that assigns HHS specific topics and firm deadlines but lacks resourcing, methodological detail, and robust accountability provisions.
Privacy and law‑enforcement access concerns versus public‑health data use
These are examples from the analysis, not a ranked list of the most-affected groups.
The clearest budget scorecard attached to this bill: what it changes for direct spending, revenue, and the deficit.
As passed by the Senate on March 23, 2026
Privacy and law‑enforcement access concerns versus public‑health data use
Likely supportive of the study and guidance as a harm‑reduction and public‑health measure, but wary of privacy and criminalization risks.
Will press that guidance emphasize confidentiality, linkage to treatment and harm‑reduction services, and protections against data misuse.
Likely cautiously supportive: views the study and subsequent guidance as reasonable evidence‑gathering before policy change.
Wants clear cost estimates, measurable benefits, and safeguards to avoid unintended harms or unfunded mandates.
Mixed support: welcomes focus on fentanyl and overdose prevention, but cautious about federal involvement that could pressure hospitals or create privacy/legal issues.
Prefers limited federal role and protection of clinical autonomy.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low-cost, noncontroversial advisory bill has reasonable prospects, but many such technical measures fail to advance amid competing priorities.
The bill has not accumulated any surfaced votes yet.
Privacy and law‑enforcement access concerns versus public‑health data use
Low-cost, noncontroversial advisory bill has reasonable prospects, but many such technical measures fail to advance amid competing prioriti…
Relative to its intended legislative type, this bill is a clearly focused study-and-guidance statute that assigns HHS specific topics and firm deadlines but lacks resourcing, methodological detail, and robust accountabi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.